Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03271931 · ClinicalTrials.gov registry record · NA

Active Choice in the EHR to Promote Statin Therapy

A NA study of Cardiovascular Diseases, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
23,066
Enrollment target
1
Study location

NCT03271931 is a NA study of Cardiovascular Diseases that has completed, run by University of Pennsylvania. The registered enrollment target is 23,066 participants, below the 26,897-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03271931, a NA study of Cardiovascular Diseases, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
23,066 participants
Enrollment target
1
Study location

Study Summary

Cardiovascular (CV) events are the leading cause of mortality in the United States. Statins have been demonstrated to be an effective tool for reducing CV events and mortality, but statins are often either not prescribed or under-prescribed for patients that meet evidence-based guidelines. In this study, we will evaluate a health system initiative using active and passive choice prompts in the electronic health record to prompt cardiologists to prescribe evidence-based statin therapy. In partnership with the health system, this will be conducted as a randomized, controlled trial to evaluate its effect.

Conditions Studied

Interventions

  • BEHAVIORAL Active choice
  • BEHAVIORAL Passive choice

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 23,066 participants
Start Date 2018-09-24
Est. Completion 2019-06-05
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03271931

The ClinicalTrials.gov registry entry for NCT03271931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23,066 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,897-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (14% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Active choice is the first listed.

NCT03271931 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03271931 about?

NCT03271931 is a clinical study titled "Active Choice in the EHR to Promote Statin Therapy". Cardiovascular (CV) events are the leading cause of mortality in the United States. Statins have been demonstrated to be an effective tool for reducing CV events and mortality, but statins are often either not prescribed or under-prescribed for patients that meet evidence-based guidelines. In this s...

What is the current status of trial NCT03271931?

This trial is currently completed. It is a NA study. The enrollment target is 23,066 participants. The study started on 2018-09-24. Estimated completion is 2019-06-05.

What conditions does trial NCT03271931 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT03271931?

The interventions under investigation include: Active choice (BEHAVIORAL), Passive choice (BEHAVIORAL).

Who is sponsoring clinical trial NCT03271931?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03271931 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.